Leadership Overview
Analogic has 5 executives leading key functions including strategy, financial oversight, imaging technology, operational systems, and corporate leadership.
Focused on advancing medical diagnostics and security screening, Analogic delivers high-precision technology to global markets while maintaining a commitment to innovation and safety in critical infrastructure and healthcare environments.
Focused on advancing medical diagnostics and security screening, Analogic delivers high-precision technology to global markets while maintaining a commitment to innovation and safety in critical infrastructure and healthcare environments.
Leadership Roles at Analogic
Ana Roque - Chief Executive Officer
Ana Roque, the Chief Executive Officer at Analogic, directs the overarching strategic vision for medical imaging and security screening solutions. Overseeing the entire corporate portfolio, the Chief Executive Officer ensures alignment between product development and global market demands. This leadership role involves managing high-level stakeholder relationships and driving long-term growth across the healthcare and aviation sectors. By prioritizing technological advancement, Ana Roque fosters a culture of precision and reliability within the organization. The Chief Executive Officer coordinates with the board to secure capital investments for research and development, ensuring the company maintains a competitive edge in computed tomography and threat detection. Through rigorous oversight of organizational performance, the Chief Executive Officer optimizes internal processes to support sustainable expansion. Ultimately, Roque secures the company's position as a leader in complex diagnostic and security systems, ensuring consistent value delivery to clients worldwide.
Will Rousmaniere - Chief Financial Officer
Will Rousmaniere, the Chief Financial Officer at Analogic, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning, reporting, and risk management, the Chief Financial Officer ensures the company maintains robust liquidity to support ongoing research in medical imaging and airport security systems. This leadership role involves analyzing market trends to guide investment decisions in digital mammography and magnetic resonance imaging technologies. By implementing stringent financial controls, Will Rousmaniere drives operational efficiency and profitability across all business units. The Chief Financial Officer collaborates with executive leadership to evaluate the economic impact of new product launches and international expansion efforts. Through meticulous budget management and strategic forecasting, the Chief Financial Officer supports the company's mission to provide advanced diagnostic tools. Ultimately, Rousmaniere ensures the financial stability required to sustain long-term innovation in the highly regulated medical and security manufacturing sectors.
Christopher Bade - Chief Operating Officer, Imaging & Detection Systems
Christopher Bade, the Chief Operating Officer, Imaging & Detection Systems at Analogic, manages the end-to-end manufacturing and supply chain operations for critical imaging hardware. Overseeing production facilities and logistics, the Chief Operating Officer ensures the seamless delivery of computed tomography and security screening systems to global clients. This leadership role involves optimizing manufacturing workflows to maintain high quality standards while meeting aggressive production timelines. By streamlining operational processes, Christopher Bade drives efficiency in the assembly of complex medical and security devices. The Chief Operating Officer coordinates with procurement and engineering teams to mitigate supply chain risks and ensure the availability of essential components. Through rigorous oversight of operational metrics, the Chief Operating Officer supports the company's ability to scale production in response to market demand. Ultimately, Bade ensures that all imaging and detection systems are manufactured with precision, supporting the company's commitment to excellence in medical and security technology.
Rocky Ostroff - President
Rocky Ostroff, the President at Analogic, executes the day-to-day business operations and drives the commercial success of the company's diverse product lines. Overseeing cross-functional teams, the President ensures that the development of medical imaging and security screening systems aligns with the broader corporate mission. This leadership role involves managing market expansion strategies and strengthening relationships with key partners in the healthcare and aviation industries. By fostering a collaborative environment, Rocky Ostroff drives the integration of new technologies into existing product portfolios. The President works closely with other executives to refine business processes and enhance customer satisfaction across all regions. Through active engagement with market stakeholders, the President identifies new opportunities for growth in diagnostic and threat detection markets. Ultimately, Ostroff directs the company's commercial efforts, ensuring that the organization remains a trusted provider of high-performance technology for medical practices and security checkpoints worldwide.
Steven Urchuk - Chief Technology Officer, Imaging & Detection
Steven Urchuk, the Chief Technology Officer, Imaging & Detection at Analogic, architects the technical roadmap for advanced diagnostic and security hardware. Overseeing the engineering teams, the Chief Technology Officer drives the development of next-generation computed tomography and threat detection systems. This leadership role involves integrating complex motion controls and imaging software to enhance performance in medical practices and airport checkpoints. By fostering innovation in digital mammography, Steven Urchuk ensures the company remains at the forefront of diagnostic accuracy. The Chief Technology Officer collaborates with product managers to translate clinical and security requirements into scalable technical solutions. Through continuous evaluation of emerging technologies, the Chief Technology Officer maintains the company's competitive advantage in global markets. Ultimately, Urchuk directs the technical evolution of the product suite, ensuring that all imaging and detection systems meet the highest standards of safety, reliability, and operational efficiency for end-users.
Explore Leadership Teams in Manufacturing
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership KT
MR
Cordis is a global medical-device company that specializes in interventional cardiovascular technologies. With more than 60 years of experience, it develops and manufactures minimally invasive devices such as guidewires, catheters, balloons, stents, and vascular closure systems to treat coronary and peripheral vascular diseases.
Company Leadership
STAAR Surgical designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. They are headquartered in Lake Forest, California.
Company Leadership BC
SS
MB
NS
Patterson Companies, Inc. distributes and sells dental and animal health products in the United States, the United Kingdom, and Canada. It operates through Dental and Animal Health segments. The companys Dental segment offers consumable products, such as infection control, restorative materials, hand instruments, and sterilization products; basic and advanced technology dental equipment; patient education systems; and office forms and stationery. This segment also develops and sells technology solutions, such as practice management software and e-commerce solutions. In addition, it offers a range of related services, including software and design, maintenance and repair, and equipment financing services. The companys Animal Health segment distributes animal health products, such as pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritionals, consumable supplies, equipment, and software to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. This segment also offers a range of value-added services to animal health customers. Patterson Companies, Inc. serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in St. Paul.
Company Leadership TP
DS
LK
Frequently Asked Questions Regarding Analogic Top Executives and Leadership Team
